FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3186511000001107: Zelapar 1.25mg oral lyophilisates (Medeus Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17350701000001112 Zelapar 1.25mg oral lyophilisates (Medeus Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
67047701000001118 Zelapar 1.25mg oral lyophilisates (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Is a Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Has active ingredient Selegiline hydrochloride false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Is a Zelapar true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Has specific active ingredient Selegiline hydrochloride true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Has dispensed dose form Conventional release oral lyophilisate true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Is pack of False Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has AMP True Zelapar 1.25mg oral lyophilisates (Medeus Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start